Featuring The Lancet’s preprint experiment, ASCO granting open access options to industry, and the 20 journals that were denied an impact factor.
Patient engagement in medical research is a priority for the pharmaceutical industry; however, patient involvement in publications is rare.
Featuring a study defending double-blind peer review, what’s next in the campaign for preregistration, and trial disclosure rates in the pharmaceutical industry.
Featuring the cost of journal subscriptions for the UK’s top universities, the open access mandate on its way through the California legislature, and a look at clinical trial disclosure rates.
Open access publishing of medical research is increasingly prevalent, but open access terminology is varied and confusing. Gold, green, bronze, hybrid, CC BY, CC BY-NC – what does it all mean, and what is the best type of open access? At the 14th Annual Meeting of the International Society of Medical Publication Professionals, a panel of stakeholders in medical publications met to discuss open access from different perspectives.
Featuring proposals for an EU open access research platform, a tribute to Professor Doug Altman, and the ramifications of preprinting medical research.
Featuring the peer reviewers accidentally re-animating the ideas of a 19th century biologist, the funders using open science to fight ebola and Kim Kardashian’s foray into academic publishing.